Cancer, particularly acute myeloid leukaemia (AML), is aggressive and also resistant to anti-cancer therapy, resulting in poor patient outcomes. Understanding how genes can be switched on and off without affecting their DNA sequence is paramount for the development of new anti-cancer therapies. AML is characterised by the abnormal proliferation of immature myeloid cells. The standard […]
European Defence Fund on track with €525 million for Eurodrone and other joint research and industrial projects
The Commission has recently adopted work programmes to co-finance joint defence industrial projects in 2019-2020 worth up to €500 million. A further €25 million have been earmarked to support collaborative defence research projects in 2019, with calls for proposals launched today. The Juncker Commission is making an unprecedented effort to protect and defend Europeans. […]
€2 billion to fast forward the creation of the European Innovation Council
Ahead of the 21-22 March European Council discussion on innovation, industry and competitiveness, the Commission takes decisive steps to set up a European Innovation Council. Global competition is intensifying and Europe needs to deepen its innovation and risk-taking capability to compete on a market increasingly defined by new technologies. That is why the Juncker […]
New intraoperative probe for breast cancer tissue
Breast cancer diagnosis has improved over the years, leading to an increasing number of surgical tumour resections in specific breast conservative surgery. An innovative probe for detecting breast cancer tissue during operation could improve retention of healthy tissue and improve local treatment outcome. As with most cancer operations, breast conserving surgery aims to completely remove […]
Pharmaceuticals in the environment: Commission defines actions to address risks and challenges
The European Commission has today adopted a Communication outlining a set of actions addressing the multifaceted challenges that the release of pharmaceuticals poses to the environment. The “Strategic Approach to Pharmaceuticals in the Environment” that the Commission presents today, identifies six action areas concerning all stages of the pharmaceutical life cycle, where improvements can be […]
Imminent anti-metastatic vaccine for prostate cancer
Prostate cancer is the most commonly diagnosed cancer in men with millions of new cases every year. European scientists have developed a novel vaccine to prevent disease metastasis, the main cause of mortality amongst advanced prostate cancer sufferers. The majority of prostate cancer patients are diagnosed at the localised, pre-metastatic stage of the disease. They […]
New technology is recognising affective states
Empathic machines and digital products may be just around the corner thanks to EU-funded project TAWNY. Today many smart products and services do not have empathy to understand humans and automatically adapt to the needs and preferences of users without explicit user interaction and feedback. The TAWNY project takes things a step further and introduce […]
101 Ideas on the Future of Research and Innovation in Europe
Título: 101 Ideas on the Future of Research and Innovation in Europe Autor: Ciencia e innovación de la UE Duración: 01:47 Resumen: El grupo de expertos RISE presenta sus propuestas de toda Europa sobre el futuro de la I + D en la política europea. Fecha de Publicación: 05-03-2019
What is the Horizon2020 Policy Support Facility?
Título: What is the Horizon2020 Policy Support Facility? Autor: Ciencia e innovación de la UE Duración: 01:50 Resumen: El Servicio de apoyo a las políticas proporciona las mejores prácticas, la experiencia independiente de alto nivel y la orientación en el campo de la I + D a petición de los Estados miembros y los países […]